Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.05.2022 | Case report

Tozinameran

Subacute (De Quervain's) thyroiditis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Pipitone G, et al. Vaccine-Induced Subacute Thyroiditis (De Quervain's) after mRNA Vaccine against SARS-CoV-2: A Case Report and Systematic Review. Infectious Disease Reports 14: 142-154, No. 1, Feb 2022. Available from: URL: https://www.mdpi.com/journal/idr Pipitone G, et al. Vaccine-Induced Subacute Thyroiditis (De Quervain's) after mRNA Vaccine against SARS-CoV-2: A Case Report and Systematic Review. Infectious Disease Reports 14: 142-154, No. 1, Feb 2022. Available from: URL: https://​www.​mdpi.​com/​journal/​idr
Metadaten
Titel
Tozinameran
Subacute (De Quervain's) thyroiditis: case report
Publikationsdatum
01.05.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-16264-y

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Paclitaxel

Case report

Vancomycin

Case report

Antineoplastics

Case report

BCG

Case report

Diltiazem